An exclusive psychedelic medicine investment seminar for family office, high net worth, angel and private equity investors.
Hosts & Participants
Evidence-based, legal psychedelic therapies to help heal depression.
Standardizing extraction and formulation of psychedelic compounds for scientific research and natural health care products for human performance.
Mindset Pharma is a psychedelic-based drug discovery business creating novel, patent-pending psychedelic compounds for treatment-resistant neurological and psychiatric disorders.
Pure Extracts, a CO2 extraction specialist with a focus on strategic distribution and product innovation in plant based compounds.
An investment firm that values its independence and its entrepreneurial spirit.
For companies looking to access the Canadian public capital markets.
What is the Psychedelic Capital Series?
An investor conference series diving deep into psychedelic medicine investment. Each month, we present a curated group of CEOs, capital advisors, and investment luminaries from around the world.
Each session features two tracks. The first looks at the bigger picture, helping investors understand the psychedelic landscape. The second is a chance to hear from the hottest companies directly, in conversation with our experts.
The topics we explore include:
- Public Markets & IPOs
- Early Stage Opportunities
- Business & Operations
- Law & Regulation
- The Future